Coronavirus (COVID-19)

Find our resources or medicines guidance summaries. Use gov.uk for the government response, and nhs.uk for health information.

Hide message

Dolutegravir

Dolutegravir will be the third integrase inhibitor (INI) to be launched in the UK and the first stand-alone INI with once-daily dosing, with no need…
Filters (1) Toggle